Zahraa Al-Delfi

Research Interests

Vaccinology Immunology Virology Infectious Diseases Biotechnology Nanomedicine

Dr Zahraa Al-Delfi

School of Medicine

College of Health

Language Competency
Arabic Can read, write, speak and understand spoken
English Can read, write, speak and understand spoken

Date Institution name Country Title
2026 University of Adelaide Australia PhD
2021 The University of Adelaide Australia Master of Biotechnology (Biomedical)
2018 The University of Adelaide Australia Bachelor of Science

Year Citation
2026 Santos, R., Mekonnen, Z. A., Yeow, A. E. L., Whelan, D. M., Al-Delfi, Z., Eyre, N. S., . . . Grubor-Bauk, B. (2026). Multi-antigen DNA vaccine targeting non-structural proteins confers robust T Cell-mediated protection against Zika virus. npj Vaccines, 11(1), 35-1-35-14.
DOI
2025 Liu, D., Wang, X., Xu, L., Al-Delfi, Z. N. S., Mekonnen, Z. A., Gao, S., . . . Zhao, C. -X. (2025). Screening lipid nanoparticles using DNA barcoding and qPCR. Colloids and Surfaces B: Biointerfaces, 251, 114598-1-114598-11.
DOI Scopus8 WoS8 Europe PMC4
2025 Garcia-Valtanen, P., Lip Yeow, A. E., Mekonnen, Z. A., Whelan, D. M., Santos, R., Al-Delfi, Z., . . . Grubor-Bauk, B. (2025). Thermostable unit solid dose formulations for subcutaneous administration of DNA vaccines.. Molecular Therapy Nucleic Acids, 36(3), 102628.
DOI Scopus2 WoS1
2022 Ryan, F. J., Hope, C. M., Masavuli, M. G., Lynn, M. A., Mekonnen, Z. A., Yeow, A. E. L., . . . Lynn, D. J. (2022). Long-term perturbation of the peripheral immune system months after SARS-CoV-2 infection. BMC Medicine, 20(1), 26-1-26-23.
DOI Scopus221 WoS216 Europe PMC226
2022 Perkins, G. B., Tunbridge, M., Salehi, T., Chai, C. S., Kireta, S., Johnston, J., . . . Coates, P. T. (2022). Concurrent vaccination of kidney transplant recipients and close household cohabitants against COVID-19. Kidney International, 101(5), 1077-1080.
DOI Scopus13 WoS11 Europe PMC13
2022 Garcia-Valtanen, P., Hope, C. M., Masavuli, M. G., Yeow, A. E. L., Balachandran, H., Mekonnen, Z. A., . . . Grubor-Bauk., B. (2022). SARS-CoV-2 Omicron variant escapes neutralising antibodies and T cell responses more efficiently than other variants in mild COVID-19 convalescents.. Cell Reports Medicine, 3(6), 100651-1-100651-17.
DOI Scopus37 WoS36 Europe PMC36
2020 Mekonnen, Z. A., Masavuli, M. G., Yu, W., Gummow, J., Whelan, D. M., Al-Delfi, Z., . . . Grubor-Bauk, B. (2020). Enhanced T cell responses induced by a necrotic dendritic cell vaccine, expressing HCV NS3. Front Microbiol, 11(559105), 1-13.
DOI Scopus9 WoS7 Europe PMC8

Year Citation
2021 Ryan, F., Hope, C., Masavuli, M., Lynn, M., Mekonnen, Z., Lip Yeow, A. E., . . . Lynn, D. (2021). Long-term perturbation of the peripheral immune system months after SARS-CoV-2 infection.
DOI Europe PMC1
2021 Garcia-Valtanen, P., Hope, C., Masavuli, M., Lip Yeow, A. E., Balachandran, H., Mekonnen, Z., . . . Grubor-Bauk, B. (2021). COVID-19 convalescents exhibit deficient humoral and T cell responses to variant of concern Spike antigens at 12 month post-infection.
DOI

Connect With Me

External Profiles

Other Links